by Jordana Choucair | Apr 7, 2022 | D.C. News
Congress may punt on a $10 billion COVID-19 preparedness funding package until the end of this month due to a disagreement over immigration policy. Republican senators are demanding a vote on an amendment to the funding package that would block the administration’s...
by Jordana Choucair | Apr 7, 2022 | Life Sciences
A new report from the American Society of Health-System Pharmacists found that drug spending in the U.S. hit $576.9 billion in 2021, a 7.7 percent increase over 2020. Hospitals accounted for $39.6 billion of that spending, with an 8.4 percent growth from 2020 to 2021....
by Jordana Choucair | Apr 6, 2022 | D.C. News
The Biden administration announced a new effort to prevent, detect, and treat long COVID-19. President Biden issued a memorandum that accelerates enrollment in the National Institutes of Health’s study of the long-term effects of COVID-19 infection and instructs the...
by Jordana Choucair | Apr 6, 2022 | Life Sciences
Advisors to the Food and Drug Administration (FDA) will start to develop a long-term strategy for COVID-19 vaccinations. The discussion is expected to include the viability of an annual COVID-19 vaccine, which would require scientific models to predict how COVID-19...
by Jordana Choucair | Apr 6, 2022 | M&A
UnitedHealth Group Inc.’s Optum business and health tech company Change Healthcare delayed their planned merger until the end of the year, ahead of an August trial to determine whether the deal can go forward. The companies said they would contest the...
by Jordana Choucair | Apr 6, 2022 | Payers
A recent Kaiser Family Foundation (KFF) poll revealed that most Americans remain concerned about out-of-pocket costs and the quality of long-term care. According to the poll, 61 percent of the public, regardless of partisanship, wants lawmakers to limit how much drug...
Recent Comments